Figure 3.

Cumulative incidence graph comparing therapy response with therapeutic versus subtherapeutic initial drug levels shows no statistically significant difference in complete or partial response to therapy at 12 weeks among a subset of patients with proven or probable invasive fungal disease (nā€‰=ā€‰46; HR: 0.45; Pā€‰=ā€‰0.07).

Chu et al. BMC Infectious Diseases 2013 13:105   doi:10.1186/1471-2334-13-105
Download authors' original image